CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 133 filers reported holding CTI BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $16,353,666 | -30.1% | 3,893,730 | 0.0% | 3.49% | -31.4% |
| Q4 2022 | $23,401,317 | +2.0% | 3,893,730 | -1.3% | 5.09% | +6.2% |
| Q3 2022 | $22,953,000 | -2.6% | 3,943,730 | -0.1% | 4.79% | -1.6% |
| Q2 2022 | $23,574,000 | +30.8% | 3,948,730 | +2.3% | 4.87% | +52.2% |
| Q1 2022 | $18,025,000 | +2807.3% | 3,859,707 | +1443.9% | 3.20% | +3197.9% |
| Q4 2021 | $620,000 | – | 250,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Legal & General Group Plc | 9,340 | $84,901 | 0.00% |
| UBS ASSET MANAGEMENT AMERICAS INC | 92,700 | $389,340 | 0.00% |
| FNY Investment Advisers, LLC | 20 | $0 | 0.00% |